Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Vector Laboratories Incorporated

Vestor have developed new and improved ways of labeling nucleic acid probes. Photoprobe® Biotin is used to randomly label any nucleic acid with biotin. The FastTag® labeling system allows nucleic acid to be easily and econom-ically labeled with any marker. The 5’ EndTag™ system provides a simple method to label only the 5’ hydroxyl groups of DNA or RNA probes.

Over the years Vector have introduced novel enzyme substrates, neuronal tracers, mounting media, streptavidin products, lectins with unique specificities, many ultrapure immunological reagents, and a variety of compounds for labeling, isolating and detecting proteins, carbohydrates and nucleic acids.


Contact Details:
30 Ingold Road
Burlingame
CA
94010
United States of America
Tel:415 697 3600
Fax:415 697 0339
Email:vector@vectorlabs.com
WWW:

www.vectorlabs.com/




Loading...

BioNews Results for Vector Laboratories Incorporated:

Dr. Reddy's Laboratories (RDY) Impressive On Both Fundamental And Technical Basis
I Stock Analyst:  Nov 9 2009 8:25PM Matching: vector laboratories
Ranbaxy's malaria molecule enters Phase III
Express Pharma:  Oct 26 2009 2:16PM Matching: vector laboratories
Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual
Pharma Live:  Oct 23 2009 2:40AM Matching: vector laboratories
Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
SmartBrief:  Oct 19 2009 7:44PM Matching: vector laboratories
Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual
Genetic Engineering News:  Oct 19 2009 2:22PM Matching: vector laboratories
Promote your company here: BioNewsCast - Press Release Distribution

View more Vector Laboratories Incorporated news.

Vector Laboratories Incorporated Clinical Trials:

Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma

Vector Laboratories Incorporated Patents:

US Patent No.Title
5854409 Pro-thiol aryl azide labelling of nucleic acids
5700921 Labeling nucleic acids
4684609 Method and substance for the enhanced labelling of cellular material

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 340 times since April 2007, the link to the organisation's website has been followed 63 times

Search for more companies in Burlingame

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Vector Laboratories Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.